NCT03299439

Brief Summary

The investigators plan to investigate the effectiveness of acupuncture at highly sensitive points, compared with lowly/non-sensitive points or no acupuncture (waiting-list), in improving pain, joint function and quality of life, among patients with KOA. The safety of acupuncture will also be assessed during the study period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
666

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 3, 2017

Completed
22 days until next milestone

Study Start

First participant enrolled

October 25, 2017

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2020

Completed
Last Updated

December 30, 2021

Status Verified

December 1, 2021

Enrollment Period

3.1 years

First QC Date

September 27, 2017

Last Update Submit

December 21, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • The change of Western Ontario and McMaster Universities Osteoarthritis index total score from baseline to 16 weeks

    It consists of 24 items assessing the knee osteoarthritis patients pain, stiffness, and physical function. Each of the 24 items will be graded on a visual analog scale ranging from 0 to 10, with higher scores reflecting more pain, stiffness and poorer physical function.

    Assessments will be conducted at baseline and 16 weeks after randomization

Secondary Outcomes (3)

  • The change of Short Form (SF)-12 health survey score from baseline to 16 weeks

    Assessments will be conducted at baseline and 16 weeks after randomization

  • The changes of knee ranges of motion (ROMs) from baseline to 16 weeks

    Assessments will be conducted at baseline and 16 weeks after randomization

  • The changes of pressure-pain threshold of the five selected acupuncture points from baseline to 16 weeks

    Assessments will be conducted at baseline and 16 weeks after randomization

Study Arms (3)

acupuncture at highly sensitive points

EXPERIMENTAL

Sterile, single-use filiform acupuncture needles (Hwato Needles, Sino-foreign Joint Venture Suzhou Hwato Medical Instruments Co., China) with a length of 40 mm and a diameter of 0.30 mm will be inserted to a depth of 15-30mm in five highly sensitive points.

Other: acupuncture

acupuncture at lowly/non-sensitive points

ACTIVE COMPARATOR

Sterile, single-use filiform acupuncture needles (Hwato Needles, Sino-foreign Joint Venture Suzhou Hwato Medical Instruments Co., China) with a length of 40 mm and a diameter of 0.30 mm will be inserted to a depth of 15-30mm in five low/non-sensitive points.

Other: acupuncture

no acupuncture (waiting-list)

NO INTERVENTION

Patients in the waiting-list group will not receive any acupuncture intervention during the study.

Interventions

a stimulation of the body or auricular points

acupuncture at highly sensitive pointsacupuncture at lowly/non-sensitive points

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants aged 40 years or older and diagnosed with mild or moderate knee osteoarthritis(KOA) are eligible to participate in the study
  • The following criteria are used for diagnosis of KOA:
  • refractory knee pain for most days in the last month;
  • joint space narrowing, sclerosis or cystic change in subchondral bone (as demonstrated in X-ray);
  • laboratory examinations of arthritis: clear and viscous synovial fluid (≥2 times) and white blood cell count \< 2000/mm3;
  • morning stiffness continues less than 30 minutes;
  • bone sound exists when joints was taking flexion and/or extension. If a patient meets criteria 1 and 2, or criteria 1, 3, 4, and 5, a diagnosis of KOA is confirmed.

You may not qualify if:

  • Patients will be excluded if they meet any of the following:
  • diagnosed with conditions leading to skeletal disorders, such as tuberculosis, tumors or rheumatism of the knee joint and rheumatoid arthritis;
  • present sprain or trauma in the lower limb;
  • unable to walk properly due to foot deformity or pain;
  • present with mental disorders;
  • present with comorbidities including severe cardiovascular disease, liver or kidney impairment, immunodeficiency, diabetes mellitus, blood disorder or skin disease;
  • females who are pregnant or lactating;
  • using physiotherapy treatments for osteoarthritis knee pain;
  • have used intra-articular injection of glucocorticoid or viscosupplementation in the past six months;
  • received knee-replacement surgery;
  • diagnosed with severe (stage 4, according to Kellgren and Lawrence radiographic classification) or late clinical stage of KOA;
  • have a swollen knee or positive result of floating patella test; or'
  • are participating or have participated in the other clinical trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

the Third Affiliated Hospital of Henan University of Traditional Chinese Medicine

Zhengzhou, Henan, 450003, China

Location

Wuhan Integrated Traditional Chinese Medicine and Western Medicine Hospital

Wuhan, Hubei, 430022, China

Location

Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University

Chengdu, Sichuan, 610041, China

Location

the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

Chengdu, Sichuan, 610075, China

Location

Related Publications (2)

  • Liu J, Li Y, Li L, Luo X, Li N, Yang X, Zhang H, Liu Z, Kang D, Luo Y, Liu Y, Jia Y, Ren Y, Yao M, Wang Y, Chen J, Maiji M, Zou K, Zhao L, Liang F, Sun X. Effects of acupuncture at acupoints with lower versus higher pain threshold for knee osteoarthritis: a multicenter randomized controlled trial. Chin Med. 2022 Jun 8;17(1):67. doi: 10.1186/s13020-022-00626-3.

  • Tang L, Jia P, Zhao L, Kang D, Luo Y, Liu J, Li L, Zheng H, Li Y, Li N, Guyatt G, Sun X. Acupuncture treatment for knee osteoarthritis with sensitive points: protocol for a multicentre randomised controlled trial. BMJ Open. 2018 Oct 2;8(10):e023838. doi: 10.1136/bmjopen-2018-023838.

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Xin Sun, Phd

    West China Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

September 27, 2017

First Posted

October 3, 2017

Study Start

October 25, 2017

Primary Completion

November 20, 2020

Study Completion

November 20, 2020

Last Updated

December 30, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations